GenSight Biologics Reports Cash Position as of March 31, 2021 and Provides Operational Update

Retrieved on: 2021-04-20 05:26:15

Tags for this article:

Click the tags to see associated articles and topics

GenSight Biologics Reports Cash Position as of March 31, 2021 and Provides Operational Update. View article details on hiswai:

Excerpt

GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Article found on: www.biospace.com